Emmerich VK, Williams JA, Hrin ML, Feldman SR, et al. Dupilumab for moderate-severe atopic dermatitis: a real-world, single-center retrospective study of 122 patients in the United States. Int J Dermatol 2023 Dec 13. doi: 10.1111/ijd.16973.
PMID: 38093434